The threat of sexually transmitted infections

Sexually Transmitted Infections (STIs) is a national health problem in Ukraine. About 400,000 new cases of syphilis, gonorrhea, chlamydia, herpes, genitourinary mycoplasmosis, genital candidiasis and trichomoniasis are registered annually in Ukraine. STIs, whose pathogens are more than 30 different bacteria, viruses and parasites, are distributed mainly due to sexual contacts (vaginal, anal, oral sex).

Microorganisms that cause STIs can also spread due to transfusion of blood products and tissue transplants. Many STIs, including chlamydia, gonorrhea, hepatitis B, HIV, HPV, HSV-2 and syphilis, can also be transmitted from mother to child during pregnancy and childbirth. A person may have STIs without obvious symptoms of the disease. Common symptoms of sexually transmitted diseases include vaginal discharge, urinary excretion in men, genital ulcers and abdominal pain.

With the highest incidence, 8 of the more than 30 known pathogens transmitted during sexual intercourse are associated. Today, 4 of these 8 infections are being treated, namely, syphilis, gonorrhea, chlamydia and trichomoniasis. The rest - hepatitis B, herpes, HIV and HPV - are viral and incurable infections, but due to treatment their effects can be reduced.

According to the results of numerous studies, the presence of STI significantly increases the risk of HIV transmission and infection by sexually transmitted infections. In particular, HIV transmission is facilitated by syphilis, genital herpes, gonorrhea, chlamydia, trichomoniasis, candidiasis, mycoplasmosis, and other sexually transmitted infections. Erosion and ulcers, inflammation, tissue damage caused by STIs, weaken the factors protecting the body from HIV infection.

Viral Hepatitis C: What is it and where to check out yourself?

Viral hepatitis C - a disease caused by a virus that can be transmitted through the blood from one person to another. The disease primarily affects the liver and predetermines to the physical and emotional state of the person, in addition, it is a potential threat to life. As a result of the virus, the liver is damaged, which can not cope with the fulfillment of vital functions. Vaccines against hepatitis C do not exist. But in many cases a patient can be cured.

Symptoms may appear and disappear. Some people have no symptoms for many years, while others may feel fatigue, sweating (especially at night), muscle aches, loss of appetite and concentration. In later stages of the disease, when the liver is damaged more seriously, jaundice, itching, internal bleeding and clogging may occur.

Risk factors:

  • Getting cosmetic services, which includ contact with blood, as well as tattoos and piercings;

  • Staying on hemodialysis and / or often getting blood transfusion (or its components);

  • Birth of a mother who has hepatitis B diagnosed;

  • Sexual relations with a person who has been diagnosed with hepatitis B virus;

  • Being affiliated with people who have or have had numerous sexual contacts or remunerated sexual services;

  • Working in the field of health or another area that is potentially in contact with the blood;

  • Accommodation with a person who has been diagnosed with hepatitis B virus

  • Staying in countries with high prevalence of hepatitis B virus;

  • Living with HIV and / or the hepatitis C virus or have chronic liver disease;

  • Injecting drug use.

It is possible to undergo examination and treatment of hepatitis C virus in one of the institutions located on the map.

Accordingly: there are three types of tests for the detection of hepatitis C infection:

1. An antibody test for VGC determines whether you have ever had a virus. Some people get rid of the virus naturally, without medical assistance;

2. The Polymerase Chain Reaction (PCR) shows whether the virus is present in your body now. If the PCR test is positive, additional testing will show the genotype (strain) of the virus;

3. Genotyping (determining the genotype of the virus): the genotype determines the treatment that you will receive.

 

Resist HIV / AIDS: A Plan to Improve the Use of Strategic Information

The epidemic of HIV infection remains a national-wide problem in Ukraine. Due to the crisis social and economic situation and complications in the eastern regions of Ukraine, it becomes increasingly difficult to predict the further development of the HIV epidemic

According to the updated estimate, at the beginning of 2018, there were 244 000 PLWH of all age categories living in Ukraine, taking into account the data of the Autonomous Republic of Crimea, the city of Sevastopol and the temporarily occupied territories of Donetsk and Lugansk. The prevalence of HIV among adults 15 years of age and older is estimated at 0.63%, in the age group of 15-49 years - 0.94%. As the 1st of October 1, 2018, 144 633 HIV-positive citizens of Ukraine, including 46 443 AIDS patients, were registered at the health care institutions; 98,936 patients received ART - 70.8% of the medical supervision group.

In order to contribute to the further development of the epidemic in the framework of the country's commitments to respond to the HIV epidemic, has been developed a Plan to Improve the Use of Strategic Information on HIV / AIDS. This document should become an instrument for informing and motivating state institutions, non-governmental organizations, international partners, other communities and organizations working in the field of HIV / AIDS.

The Government submitted a bill to approve the TB program until 2021

On the 14th of January, in Parliament, a draft of Law of Ukraine No. 9467 "On Approval of the National Targeted Social Program for Tuberculosis Control in 2018-2021" was registered.

The document states that the main goal of the program is to stabilize the sityation with tuberculosis in Ukraine, reduce its mortality rate and increase the efficiency of treatment of patients. The program provides for a rapid reform of the approaches to providing anti-TB health care to the population in Ukraine. One of the new strategic directions is the implementation of a model of anti-TB care tailored to people's needs.

"Implementation of the program will provide 100% access to the treatment of all patients with tuberculosis through the introduction of a new approach that is as much as possible focused on the patient. First of all, this is the transition to outpatient care for tuberculosis patients, observing the modern principles of infection control, the introduction of short-term regimens of treatment with new drugs already registered in Ukraine in 2018 ", - commented the first deputy of general director of the Center for Public Health of the Ministry of Health of Ukraine Viktor Lyashko

The program provides access to timely diagnosis of tuberculosis by purchasing the necessary materials for molecular-genetic research methods, which allow for accurate diagnosis within two hours.

 

Partners

 

Need to talk to us

Phone: +38 (044) 569 28 52
Fax: +38 (044) 569 28 52
Staronavodnickaya 13A st., office 35.

Email: aids-institute@aids-institute.org

About us

Back to top
ankara otel şarkı sözleri iç mimarlık ankara rent a car ankara seks izle